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Abstract Atp11p (Atpaf1p; F1-ATPase assembly factor 1) and
Atp12p (Atpaf2p; F1-ATPase assembly factor 2) are proteins
required for the assembly of L (F1-L) and K (F1-K) subunits into
the mitochondrial ATPase. Here we report about 100 times
lower levels of ATPAF1 and ATPAF2 transcripts in relation
to the mRNA levels of F1-K and F1-L in a range of mouse
tissues. Quantitative reverse-transcription polymerase chain re-
action revealed nearly constant ATPAF1 expression in all tis-
sues in both adult and 5-day-old mice (up to two-fold di¡er-
ences), indicating that ATPAF1 rather behaves like a
maintenance gene. In contrast, ATPAF2 expression di¡ered
up to 30-fold in the tissues analysed. ATPAF2 tissue-speci¢c
expression was also found to correlate well with mRNA levels
of both F1-K and F1-L (BATEkidney, livers heart, brains
skeletal muscle), showing the highest mRNA level in the ther-
mogenic, ATPase-poor brown adipose tissue, which is charac-
terised by a 10-fold decrease in ATPase/respiratory chain stoi-
chiometry relative to the other tissues.
1 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Mammalian ATP synthase (ATPase) is an oligomeric en-
zyme consisting of a catalytic F1 moiety which is connected to
the proton-translocating component (FO) via central and pe-
riphery stalks [1]. The F1 part is comprised of ¢ve nuclear-
coded subunits that are present in the stoichiometric ratio,
K3L3QNO [2]. The FO sector is composed of 11 di¡erent sub-
units, which are encoded either by nuclear or mitochondrial
DNA [1]. Therefore, the biosynthesis of ATPase is a complex
process dependent on a coordinate expression from both ge-
nomes, import machinery and the assembly pathway itself.
Studies in yeast identi¢ed ¢ve chaperone-type factors neces-
sary for assembly of the functional enzyme. Atp10p and
Atp22p were found to mediate FO assembly [3,4], while
Atp11p, Atp12p and Fmc1p are required for the F1 part
[5,6]. Fmc1p is essential at elevated growth temperatures but
FMC1 deletion can be rescued by overexpression of Atp12p
[6]. Recently, human orthologues of Atp11p and Atp12p (At-
paf1p and Atpaf2p according to gene nomenclature) were also
identi¢ed. Like the yeast proteins, human Atp11p has chap-
erone-like activity towards the L subunit and human Atp12p
has been proposed to interact with the K subunit [7]. Genes
coding for Atp11p and Atp12p seem to be generally present in
eukaryotes [7,8] ; however, it is not clear whether besides the
chaperone activity they could also be involved in the regula-
tion of the mitochondrial content of ATPase.
An interesting mammalian model for studying ATPase as-
sembly factors could be provided by brown adipose tissue,
which has a high content of mitochondria but about 10 times
lower amount of ATPase in comparison with respiratory
chain enzymes [9^11]. Biosynthesis of the c subunit of the
FO channel and the expression of the cP1 gene in particular
determines the amount of ATPase in brown adipose tissue
and most probably in other tissues [12^14]. Additional control
mechanisms have been proposed, involving expression of tis-
sue-speci¢c isoforms of the Q subunit [15,16] and transcrip-
tional and post-transcriptional regulation of L subunit expres-
sion [17^20].
The aim of the present study was to evaluate how ATPAF1
and ATPAF2 genes are expressed in mammalian tissues and
how their expression is related to the mRNA levels for corre-
sponding F1 subunits, K and L, with which they are supposed
to interact.
2. Materials and methods
2.1. Animals
Mice of Balb/c inbred strain were kept at 22‡C and 12-h light/12-h
dark cycle with standard diet and water ad libitum. Both 2-month-old
adult and 5-day-old young mice were killed by cervical dislocation
and tissue samples were frozen in liquid nitrogen and stored at
370‡C until RNA extraction.
2.2. Northern blot analysis
RNA Blue reagent (Top-Bio, Czech Republic) was used for total
RNA isolation, polyAþ RNA was isolated from human muscle ob-
tained from orthopedical operation using the Micro-Fast Track 2.0
kit (Invitrogen). RNA was separated on a 1.25% (w/v) agarose gel
(containing 20 mM MOPS pH 7.0, 6.7% (v/v) formaldehyde, 50 mM
sodium acetate and 10 mM EDTA) and was transferred to a Hybond-
N membrane (Amersham Biosciences, UK) by capillary blotting over-
night. The membrane was prehybridised at 42‡C for 2 h (5U SSC pH
7.0, 5U Denhardt’s, 0.5% (w/v) SDS, 50 mM sodium phosphate pH
6.5, 50% (v/v) formamide and 100 Wg/ml herring sperm DNA), hybrid-
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isation was carried out overnight at 42‡C in the same solution con-
taining [32P]dATP-labelled cDNA, labelled by random priming (Am-
bion, USA). Blots were hybridised to cDNA probes corresponding to
the 341 bp fragment of human F1-L (NM_001686, bases 870^1210),
the 474 bp fragment of human ATPAF1 (BC_008498, bases 1070^
1544) and the 639 bp fragment of human ATPAF2 mRNA
(NM_145691.2, bases 217^855). The radioactive signal was quanti¢ed
using the BAS-5000 system (Fuji, Japan). Blots were stripped and
rehybridised sequentially.
2.3. Quantitative reverse-transcription polymerase chain reaction
(RT-PCR)
Primers (Table 1) were designed using the PrimerSelect software
(version 4.04, DNASTAR Inc.). 2 Wg of total RNA was reverse-tran-
scribed in 20 Wl reaction with SuperScript II (Invitrogen). Quantitative
RT-PCR was performed on a LightCycler (Roche) in a 10 Wl volume
with 0.5 WM primer concentration. HotStarTaq DNA polymerase,
bu¡er, nucleotides and MgCl2 were included in the QuantiTect
SYBR Green PCR kit (Qiagen). 2.5 mM MgCl2 was found to be
optimal for all primer pairs. Initial 15 min denaturation at 95‡C to
activate the HotStarTaq polymerase was followed by 45 cycles with a
94‡C denaturation for 15 s, 60‡C annealing for 25 s and 72‡C exten-
sion for 20 s. Fluorescent product was detected at the end of each
elongation phase. Speci¢city of the PCR was con¢rmed by melting
curve analysis (95‡C for 0 s, cooling down to 68‡C for 15 s, heating to
95‡C at a rate of 0.1‡C/s) and agarose gel electrophoresis (Fig. 1).
Standard curves were generated after serial dilutions of a cDNA ob-
tained from adult heart. Quanti¢cation data were obtained in tripli-
cate from two or three independent RNA isolations and analysed by
Second Derivative Maximum Method with the LightCycler analysis
software (version 3.3, Roche). Pooled tissues of three animals were
used for each RNA isolation from heart and brown adipose tissue
from young mice. Levels of GAPDH (glyceraldehyde-3-phosphate de-
hydrogenase) mRNA were used to correct inter-sample variation.
3. Results
3.1. ATPAF1 and ATPAF2 transcripts are low-abundant
Northern blot analysis of total RNA from human muscle,
rich in the content of ATPase, revealed a speci¢c but very
weak signal of both ATPAF1 and ATPAF2 mRNAs. This
signal could be increased by using polyAþ RNA but its com-
parison with the signal of F1-L mRNA clearly indicated that
ATPAF1 and ATPAF2 genes are expressed at a much lower
level (Fig. 2). Thus, in further experiments, we used quantita-
tive RT-PCR analysis to examine ATPAF1 and ATPAF2
mRNA levels in di¡erent mouse tissues simultaneously with
F1-K and F1-L transcripts.
3.2. Expression of genes encoding K and L subunits of the
catalytic moiety of ATPase
The expression of F1-K and F1-L was analysed in several
mouse tissues with high energy demands (Fig. 3), namely in
heart, kidney, brown adipose tissue and liver from both adult
and young animals. In addition, muscle and brain from adult
mice were also used. F1-K and F1-L transcripts were normal-
ised to the level of GAPDH mRNA [21] and results were
expressed relatively to the value from adult heart, de¢ned as
1. RT-PCR revealed tissue-speci¢c di¡erences in F1-K mRNA
levels within the range of 0.3^2.0, and similarly the content of
F1-L transcript varied between 0.3 and 2.8 in adult tissues.
F1-K and F1-L tissue pro¢les were alike, with the highest
mRNA levels observed in brown adipose tissue and the lowest
in muscle, resulting in seven- to nine-fold di¡erence in both
mRNA levels. The same expression pro¢les of F1-K and F1-L
were found in 5-day-old mice. Resulting F1-K/F1-L mRNA
ratios ranged between 0.6 and 1.0 in all tissues tested and
clearly con¢rmed the similarity between F1-K and F1-L expres-
sion patterns.
3.3. ATPAF1 expression even contrasts with variable
expression of ATPAF2, which is the highest in brown
adipose tissue
We further quanti¢ed the mRNA levels of ATPAF1 and
ATPAF2, which were also normalised to GAPDH transcript
(Fig. 4). ATPAF1 mRNA levels remained steady in all tissues
and did not exceed a two-fold di¡erence in adults or the
young. Conversely, ATPAF2 mRNA levels were much more
Table 1
Primers for real-time RT-PCR analysis
mRNA Accession number Primer sequences (5P^3P) Product bp
Forward Reverse
ATPAF1 XM_204176 CAGTGCATCGCCAATCAGGTTCAG CGTTTCAGTTCGGCTCCAAGTCCA 155
ATPAF2 NM_145427 AGCATCCCTACCCAGACCCGAGAG CAATCAGGCCCAAAGTCAGCAACA 127
F1-K NM_007505 TATGCGGGTGTACGGGGTTATCTT TGAGCTTTGCGTCTGACTGTTCTG 157
F1-L NM_016774 GCAGGAAAGGATCACCACCACCAA CAGCAATAGCCCGGGACAACACAG 146
GAPDH M32599.1 GAGCGAGACCCCACTAACATCAAA TGGGGGCATCGGCAGAAGG 154
Fig. 1. Agarose gel electrophoresis of ATPAF1, ATPAF2, F1-K and
F1-L PCR products.
Fig. 2. Northern blot analysis of ATPAF1, ATPAF2 and F1-L
mRNAs. Indicated amounts of polyAþ RNA from human muscle
were used.
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variable, and likewise F1-K and F1-L transcripts, reached a
maximum in brown fat, were considerably lower in kidney
and liver, decreased further in heart and brain and were the
lowest in muscle. ATPAF2 mRNA levels ranged between 0.6
and 17 in the tissues tested, which corresponded to a 30-fold
di¡erence. Interestingly, the expression in brown fat was
about one order of magnitude higher than in other tissues;
in three independent experiments we found a 14^21-fold high-
er level of ATPAF2 mRNA in adult brown fat than in heart,
and a 9^10-fold di¡erence was present in young animals. Con-
sequently, the resulting ATPAF2/ATPAF1 ratios in mouse
tissues mirrored the expression pro¢le of ATPAF2.
Quantitative RT-PCR further con¢rmed a large excess of
F1-K and F1-L mRNAs in relation to ATPAF1 and ATPAF2
transcripts. Analysis of crossing points suggested 1.9 and 2.3
orders of magnitude lower levels of ATPAF1 and ATPAF2
transcripts in comparison with F1-L and F1-K mRNAs, respec-
tively. Even in the case of brown fat, there is about a 10-fold
di¡erence between ATPAF2 and F1-K mRNA levels.
4. Discussion
Our quantitative analysis of ATPAF1 and ATPAF2 tran-
scripts revealed about 100 times lower expression in compar-
ison to F1-K, F1-L and GAPDH genes in various mouse tis-
sues. Several observations support either qualitatively or
quantitatively these results : Northern blot detection of assem-
bly proteins mRNAs gave a poor signal in relation to F1-L
mRNA (this study); similarly Northern blot analysis of poly-
Aþ RNA with a radioactive probe to 3P-UTR of ATPAF2
resulted in a barely visible signal in human tissues in compar-
ison with the expression of several other genes located on
chromosome 17p11.2 [22]. Furthermore, Serial Analysis of
Gene Expression (SAGE [23]) data, which are available via
a public resource (http://www.ncbi.nih.gov/SAGE/ [24]),
showed the following levels of expression in normal human
tissues: ATPAF1, ATPAF26F1-K, F1-L6GAPDH with ap-
proximately 10-fold di¡erence in expression level between ad-
jacent groups. Our quantitative RT-PCR studies on human
¢broblasts (data not shown) were in good agreement with
SAGE results, which unfortunately cannot be obtained for
ATPAF1 and ATPAF2 transcriptional abundance in mouse
tissues due to the lack of data in the resource. Nonetheless,
SAGE of F1-K, F1-L and GAPDH expression levels in mouse
tissues have led to the same conclusion as was reached in the
present study.
Northern blot analysis has been mainly used to study the
expression of F1-K and F1-L in mammalian tissues so far.
High similarity between F1-K and F1-L expression pro¢les
and constant F1-K/F1-L mRNA ratios in mouse tissues includ-
ing slightly higher F1-L expression in brown adipose tissue
relatively to F1-K mRNA are consistent with previous studies
[12]. Only small di¡erences in levels of F1-L between adults
and the young were observed in brown adipose tissue of mice
[19] or in rat liver [25]. Some authors reported signi¢cantly
higher expression of F1-K or F1-L in heart compared to several
other tissues where content of F1-K or F1-L transcripts varied
[14,26,27]. Some discrepancies between individual studies may
be in the way of data evaluation. There is a general tendency
to correct inter-sample variation by the use of an internal
standard whose mRNA levels should not vary under the ex-
perimental conditions used [28]. GAPDH was considered as a
suitable reference for expression analysis in human tissues
[21]. Accordingly, we did not see signi¢cant variation of
GAPDH expression in samples from the same starting amount
of RNA. Moreover, the use of L-actin as a reference gene
resulted in similar expression pro¢les (data not shown). De-
spite the di¡erences among individual studies, an apparent
Fig. 3. Tissue expression pro¢le of F1-K and F1-L mRNAs in adult and 5-day-old mice analysed by quantitative RT-PCR. Transcript levels are
normalised to GAPDH mRNA and are expressed relative to the mean value from adult heart, which was set to 1. Data are meansVS.D.; au,
arbitrary units; BAT, brown adipose tissue.
Fig. 4. Tissue expression pro¢le of ATPAF1 and ATPAF2 mRNAs in adult and 5-day-old mice analysed by quantitative RT-PCR. Transcript
levels are normalised to GAPDH mRNA and are expressed relative to the mean value from adult heart, which was set to 1. Data are
meansVS.D.; au, arbitrary units; BAT, brown adipose tissue.
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analogy between F1-K and F1-L expression that we found was
not at all a¡ected by correlation to a reference gene.
The tissue distribution of ATPAF2 transcript closely resem-
bles those of F1-K and F1-L and is in sharp contrast to the
nearly constant ATPAF1 mRNA level. This suggests that
ATPAF1 behaves more like a maintenance gene, which serves
the cell with a constitutive expression of the chaperone. AT-
PAF2, F1-K and F1-L transcription might be, at least partly,
under a similar control mechanism, which is probably not the
control step of ATPase content as indicated by the high tran-
scripts’ content in brown fat. Nonetheless, mRNA level is not
necessarily the indicator of protein level because mRNA
stability, half-time, subcellular localisation and resulting
translational e⁄ciency are subjected to a complex regulation
in mammalian cells. Indeed, high mRNA levels of most ATP-
ase subunits in brown fat contrast with low ATPase content
compared to other tissues [12,17].
Promoters of F1-K and F1-L genes di¡er and are known to
be controlled by distinct regulatory factors, which are some-
how e¡ective in uniformly regulating the transcriptional activ-
ity of these genes. USF2 [29], YY1 [30] and COUP-TFII/
ARP-1 [31] represent experimentally veri¢ed F1-K trans-acting
factors. Transcription control of the F1-L gene involves a
proximal CCAAT box essential for basal expression [32,33],
a far-upstream enhancer [34], an OXBOX/REBOX element
involved in myogenic cell expression [33] and a close upstream
Ets domain with an adjacent GC-rich region facilitating the
binding of NRF2/GABP and Sp1, respectively [19].
As no theoretical or functional studies of transcriptional
control of ATPAF1 and ATPAF2 genes are available yet,
we used GenomatixSuite software (http://www.genomatix.de)
for prediction of transcription factor binding sites in putative
promoters of human, mouse and rat ATPAF1 and ATPAF2
genes. Both genes are devoid of TATA-box and TATA-less
promoters were identi¢ed for example for F1-K [35], F1-L [26],
F1-Q [36] and cytochrome c oxidase subunit IV genes [37].
Proposed modules in ATPAF1 promoters did not contain
any transcription binding site known to be involved in the
regulation of mammalian mitochondrial biogenesis [38]. On
the other hand, ATPAF2 genes seem to share potential regu-
latory elements with genes coding for ATPase subunits and
other mitochondrial proteins (Table 2). Predicted E-box mo-
tifs could provide binding sites for USF [39]. Sp1 and YY1
are other elements that might play a regulatory role in AT-
PAF2 expression. Sp1 has been shown to be involved in the
regulation of F1-L, ANT2, and cytochrome c oxidase genes;
similarly, YY1 can have a profound e¡ect on cytochrome c
oxidase biogenesis (for review see [38]).
In conclusion, ATPAF1 and ATPAF2 genes di¡er signi¢-
cantly in their expression pro¢les. ATPAF2 expression resem-
bles the expression patterns of F1-K and F1-L genes with the
following tissue distribution: BATEkidney, livers heart,
brains skeletal muscle. ATPAF1 shows constant expression
in the tissues tested, which is a feature of housekeeping genes.
Unlike ATPAF1, ATPAF2 possibly shares transcriptional reg-
ulatory elements common to ATPase or other mitochondria-
related genes.
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